These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8314358)

  • 21. Correlation between peripheral hemodynamic changes and left ventricular diastolic function in hypertensive patients treated with urapidil.
    Arosio E; Pancera P; Sheiban I; Priante F; Ribul M; De Marchi S; Tonni S; Lechi A
    J Hum Hypertens; 1996 Mar; 10(3):171-6. PubMed ID: 8733035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension.
    Savolainen A; Keto P; Poutanen VP; Hekali P; Standertskjöld-Nordenstam CG; Rames A; Kupari M
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):99-104. PubMed ID: 8656666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemodynamic effects of prazosin combinations during dynamic and isometric exercise.
    Lilja M; Ikäheimo M; Mattila MJ; Jounela AJ
    Ann Clin Res; 1985; 17(6):316-22. PubMed ID: 3913379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
    Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
    Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients.
    Komai N; Ohishi M; Morishita R; Moriguchi A; Kaibe M; Matsumoto K; Rakugi H; Higaki J; Ogihara T
    Am J Hypertens; 2002 Jun; 15(6):499-506. PubMed ID: 12074350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study].
    Pannier B; Guérin A; London G; Asmar R; Safar M;
    Arch Mal Coeur Vaiss; 2002 Sep; 95 Spec No 6():11-6. PubMed ID: 12407781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular response to dynamic treadmill exercise in patients with essential hypertension before and after therapy with atenolol or captopril.
    Shah PK; Lakhotia M; Chittora M; Mehta S; Mehta S; Vyas R; Parihar M
    J Assoc Physicians India; 1990 Oct; 38(10):781-4. PubMed ID: 2084084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of cilazapril in an elderly and nonelderly hypertensive general practice population.
    Dollow S; Murray N; Little S
    J Hum Hypertens; 1994 Oct; 8(10):781-4. PubMed ID: 7837216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The acute effects of cilazapril on pulmonary function tests and arterial blood gas changes in patients with pulmonary hypertension.
    Tavli T; Sekuri C; Goktalay T; Uyanik BS; Ari Z
    Int J Clin Pharmacol Res; 2003; 23(2-3):53-9. PubMed ID: 15018019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remodeling of resistance arteries in human hypertension: effects of cilazapril, an angiotensin-I-converting enzyme inhibitor.
    Schiffrin EL
    Cardiology; 1995; 86 Suppl 1():16-22. PubMed ID: 7614501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of casual ambulatory and self-measured blood pressure in a long-term study with cilazapril and atenolol.
    Grüne S; Weisser B; Kraft K; Del Bufalo A; Binswanger B; Mengden T; Spühler T; Greminger P; Moccetti T; Vetter H
    Am J Med; 1993 Apr; 94(4A):71S-74S. PubMed ID: 8488866
    [No Abstract]   [Full Text] [Related]  

  • 35. Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
    Schiffrin EL
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S13-8. PubMed ID: 8723394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between sympathetic activity and response to treatment with atenolol in hypertensive patients. Investigation group of the study of efficiency and tolerance of atenolol in hypertensive patients with increase in the sympathetic activity].
    de la Sierra A
    Med Clin (Barc); 1999 Jun; 113(2):41-5. PubMed ID: 10425617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of cilazapril on fibrinolytic system in hypertensive patients.
    Hosgor I; Ahmad S
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):101-5. PubMed ID: 18180626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
    Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
    Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril].
    Sabatini D; Fazio S; Cittadini A; Biondi B; Lucariello A; Picano T; Saccà L
    Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of cilazapril on left ventricular function and myocardial perfusion in patients with essential hypertension (hypertensive disease) stage II].
    Karpov RS; Pavliukova EN; Kapishchenko TD; Chernov VI
    Ter Arkh; 1995; 67(9):50-3. PubMed ID: 7495043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.